S Young1, R A González1, L Mutch2, I Mallet-Lambert2, L O'Rourke2, N Hickey1, P Asherson2, G H Gudjonsson3. 1. Division of Brain Sciences,Department of Medicine,Centre for Mental Health,Imperial College,London,UK. 2. Institute of Psychiatry,Psychology and Neuroscience,King's College London,UK. 3. Reykjavik University,Reykjavík,Iceland.
Abstract
BACKGROUND: Attention deficit hyperactivity disorder (ADHD) is overrepresented in prison, making it imperative to identify a screening tool that can be quickly applied to efficiently detect the disorder. We explored the discrimination ability of a widely used ADHD screen, the Barkley Adult ADHD Rating Scale (BAARS-IV), against a clinical diagnostic interview. A brief version of the screen was then developed in order to simplify its use in the prison context, and maximize its diagnostic properties. METHOD: A cross-sectional study of 390 male prison inmates was performed in the UK, all participants were screened and interviewed via the Diagnostic Interview for ADHD in Adults 2.0 (DIVA-2). RESULTS: A total of 47 (12.1%) inmates screened positive for ADHD using the full BAARS-IV, and 96 (24.6%) were clinically diagnosed, for a sensitivity of 37.9 and a specificity of 96.3. Our models identified the six items that most predicted ADHD diagnosis, with adjusted odds ratios ranging from 2.66 to 4.58. Sensitivity, specificity and accuracy were 0.82, 0.84 and 0.84, respectively, for the developed brief scale, and 0.71, 0.85 and 0.81 for its validation. Weighted probability scores produced an area under the curve of 0.89 for development, and 0.82 for validation of the brief scale. CONCLUSIONS: The original BAARS-IV performed poorly at identifying prison inmates with ADHD. Our developed brief scale substantially improved diagnostic accuracy. The brief screening instrument has great potential to be used as an accurate and resource-effective tool to screen young people and adults for likely ADHD in the criminal justice system.
BACKGROUND:Attention deficit hyperactivity disorder (ADHD) is overrepresented in prison, making it imperative to identify a screening tool that can be quickly applied to efficiently detect the disorder. We explored the discrimination ability of a widely used ADHD screen, the Barkley Adult ADHD Rating Scale (BAARS-IV), against a clinical diagnostic interview. A brief version of the screen was then developed in order to simplify its use in the prison context, and maximize its diagnostic properties. METHOD: A cross-sectional study of 390 male prison inmates was performed in the UK, all participants were screened and interviewed via the Diagnostic Interview for ADHD in Adults 2.0 (DIVA-2). RESULTS: A total of 47 (12.1%) inmates screened positive for ADHD using the full BAARS-IV, and 96 (24.6%) were clinically diagnosed, for a sensitivity of 37.9 and a specificity of 96.3. Our models identified the six items that most predicted ADHD diagnosis, with adjusted odds ratios ranging from 2.66 to 4.58. Sensitivity, specificity and accuracy were 0.82, 0.84 and 0.84, respectively, for the developed brief scale, and 0.71, 0.85 and 0.81 for its validation. Weighted probability scores produced an area under the curve of 0.89 for development, and 0.82 for validation of the brief scale. CONCLUSIONS: The original BAARS-IV performed poorly at identifying prison inmates with ADHD. Our developed brief scale substantially improved diagnostic accuracy. The brief screening instrument has great potential to be used as an accurate and resource-effective tool to screen young people and adults for likely ADHD in the criminal justice system.
Authors: Jan C Román-Ithier; Rafael A González; María C Vélez-Pastrana; Gloria M González-Tejera; Carmen E Albizu-García Journal: Crim Behav Ment Health Date: 2016-07-26
Authors: Susan Young; Rafael A González; Moshe Fridman; Paul Hodgkins; Keira Kim; Gisli H Gudjonsson Journal: BMC Psychiatry Date: 2018-06-22 Impact factor: 3.630
Authors: Susan Young; Rafael A González; Moshe Fridman; Paul Hodgkins; Keira Kim; Gisli H Gudjonsson Journal: BMC Psychiatry Date: 2018-06-25 Impact factor: 3.630
Authors: Susan Young; Gisli Gudjonsson; Prathiba Chitsabesan; Bill Colley; Emad Farrag; Andrew Forrester; Jack Hollingdale; Keira Kim; Alexandra Lewis; Sarah Maginn; Peter Mason; Sarah Ryan; Jade Smith; Emma Woodhouse; Philip Asherson Journal: BMC Psychiatry Date: 2018-09-04 Impact factor: 3.630